These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 960746)

  • 21. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].
    Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of chronic hepatitis].
    Dioguardi N
    Minerva Med; 1974 Nov; 65(82):4261-6. PubMed ID: 4431580
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with immunosuppressive therapy in chronic aggressive hepatitis].
    Shimelpfenig V; Vagner K; Toier D; Shnaider G; Khekht A; Shimelpfenig R
    Vutr Boles; 1972; 11(3):120-3. PubMed ID: 4679965
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 26. [Multicenter clinical evaluation of immunosuppressive therapy in chronic aggressive hepatitis].
    Pol Tyg Lek; 1975 Jun; 30(26):1093-6. PubMed ID: 1135090
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aggressive chronic hepatitis and non-alcoholic cirrhosis of moderate activity and immunosuppressive treatment].
    de Groote J; Fevery J; Vandenbroucke J
    Arch Fr Mal App Dig; 1971 Dec; 60(12):664-9. PubMed ID: 5158156
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of immunosuppressive therapy in chronic hepatitis].
    Buligescu L
    Med Interna (Bucur); 1972 Mar; 24(3):277-84. PubMed ID: 4112750
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of immunoglobulins and the histological picture under immunosuppressive therapy in chronic liver diseases].
    Bauch K; Büttner W; Lewicki J; Dempe A; Zimmermann S
    Z Arztl Fortbild (Jena); 1973 Jul; 67(14):705-10. PubMed ID: 4774636
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone.
    Mackay IR
    Q J Med; 1968 Jul; 37(147):379-92. PubMed ID: 4175634
    [No Abstract]   [Full Text] [Related]  

  • 31. [Physiopathology of chronic hepatitis. The dynamics of the immunological changes in active chronic hepatitis and their evolution during therapeutic immunosuppression].
    Bittman E; Udrescu E; Bordeianu A; Boroş I; Metz L; Nicolaescu T
    Physiologie; 1982; 19(3):203-9. PubMed ID: 6183702
    [No Abstract]   [Full Text] [Related]  

  • 32. Phytohaemagglutinin-induced lymphocyte transformation and histologic findings in patients with chronic aggressive hepatitis before and during immunosuppressive therapy.
    Pappas A; Von Seebach HB; Schwarze G; Reikowski H; Jost H; Jung M; Scheurlen PG
    Beitr Pathol; 1975 Dec; 156(3):197-207. PubMed ID: 1218023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of treatment of chronic aggressive hepatitis with immunosuppressive drugs].
    Maleev A; Stoianov S; Trenchev P
    Vutr Boles; 1972; 11(3):117-20. PubMed ID: 4679964
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoaggression and immunodepression in chronic hepatitis physiopathology.
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Boroş I; Moucha R; Jinga V; Gheorghe N; Metz L; Ciontescu L; Pintilescu V
    Rev Roum Physiol; 1974; 11(3):239-52. PubMed ID: 4842047
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis.
    Eroğlu Y; Düzovali O; Kavukçu S; Irken G; Büyükgebiz B
    Turk J Pediatr; 1997; 39(4):565-71. PubMed ID: 9433162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term immunosuppressive treatment of chronic aggressive hepatitis].
    Kiczka W; Juszczyk J
    Pol Tyg Lek; 1974 Apr; 29(14):571-4. PubMed ID: 4828031
    [No Abstract]   [Full Text] [Related]  

  • 37. [Various results of immunologic studies on chronic liver diseases].
    Loginov AS; Jarceva AM
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):105-8. PubMed ID: 4655067
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic hepatitis with immunosuppressive agents].
    Klages HD; Lederbogen K; Schneider W
    Med Klin; 1970 Aug; 65(34):1490-5. PubMed ID: 5521073
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term therapy of liver diseases].
    Renger F; Dökert B
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:165-8. PubMed ID: 4728085
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoimmunity and immunosuppressive therapy in active chronic hepatitis.
    Eddleston AL; Murray-Lyon IM; Williams R
    Med Chir Dig; 1973; 2(6):319-21. PubMed ID: 4792025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.